Jayamanne: It focused on the majority of Australians who don't engage with their superannuation and stay in that default fund, even if it is an optimal for their retirement goals. So, 90% of ...
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver ...